Minor extended-spectrum β-lactamases

被引:2
作者
Akinci, Esragul [2 ]
Vahaboglu, Haluk [1 ]
机构
[1] Kocaeli Univ, Tip Fak, Enf Hst & Klin Mikr Dept, TR-41380 Kocaeli, Turkey
[2] Ankara Numune Egitim & Arastirma Hastanesi, Enf Hst & Klin Mikr Klin, TR-06100 Ankara, Turkey
关键词
beta-lactamase; Acinetobacter; antimicrobial drug resistance; Escherichia coli; Pseudomonas aeruginosa; CTX-M; PSEUDOMONAS-AERUGINOSA; ACINETOBACTER-BAUMANNII; ESCHERICHIA-COLI; CLINICAL ISOLATE; GENETIC ENVIRONMENT; PLASMIDIC CEFOTAXIMASE; MOLECULAR EPIDEMIOLOGY; SALMONELLA-TYPHIMURIUM; NOSOCOMIAL OUTBREAK;
D O I
10.1586/ERI.10.119
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Over the last few decades, various extended-spectrum beta-lactamases (ESBLs), which are remotely related to the classical TEM and SHV families, have emerged. Among these, CTX-M, VEB and PER variants are of particular interest due to their widespread dissemination. This article will focus on these emerging ESBLs. CTX-M was first identified from an Escherichia coli strain in Germany and since then, a rapidly growing family of ESBLs has formed worldwide. There are now more than 90 CTX-M variants. VEB-1 ESBL is widespread in Southeast Asia. It was first identified in an E. coli strain isolated from a Vietnamese boy in 1996. After the initial discovery, it spread to other species. PER-1, now reported from various continents, was restricted to Turkish hospitals for years after the first identification in a strain of Pseudomonas aeruginosa in 1993. The worldwide dissemination of ESBLs is a healthcare crisis that deserves special attention.
引用
收藏
页码:1251 / 1258
页数:8
相关论文
共 88 条
[2]   Novel genetic structure associated with an extended-spectrum β-lactamase blaVEBGene in a Providencia stuartii clinical isolate from Algeria [J].
Aubert, D ;
Naas, T ;
Lartigue, MF ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3590-3592
[3]   Functional and structural characterization of the genetic environment of an extended-spectrum β-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India [J].
Aubert, D ;
Girlich, D ;
Naas, T ;
Nagarajan, S ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3284-3290
[4]   IS1999 increases expression of the extended-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa [J].
Aubert, D ;
Naas, T ;
Nordmann, P .
JOURNAL OF BACTERIOLOGY, 2003, 185 (17) :5314-5319
[5]   Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland [J].
Baraniak, A ;
Fiett, J ;
Hryniewicz, W ;
Nordmann, P ;
Gniadkowski, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) :393-396
[6]   Characterization of beta-lactamase gene bla(PER-2,) which encodes an extended-spectrum class A beta-lactamase [J].
Bauernfeind, A ;
Stemplinger, I ;
Jungwirth, R ;
Mangold, P ;
Amann, S ;
Akalin, E ;
Ang, O ;
Bal, C ;
Casellas, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :616-620
[7]   A NEW PLASMIDIC CEFOTAXIMASE FROM PATIENTS INFECTED WITH SALMONELLA-TYPHIMURIUM [J].
BAUERNFEIND, A ;
CASELLAS, JM ;
GOLDBERG, M ;
HOLLEY, M ;
JUNGWIRTH, R ;
MANGOLD, P ;
ROHNISCH, T ;
SCHWEIGHART, S ;
WILHELM, R .
INFECTION, 1992, 20 (03) :158-163
[8]   A NEW PLASMIDIC CEFOTAXIMASE IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
BAUERNFEIND, A ;
GRIMM, H ;
SCHWEIGHART, S .
INFECTION, 1990, 18 (05) :294-298
[9]   Influx of extended-spectrum β-lactamase producing enterobacteriaceae into the hospital [J].
Ben-Ami, R ;
Schwaber, MJ ;
Navon-Venezia, S ;
Schwartz, D ;
Giladi, M ;
Chmelnitsky, I ;
Leavitt, A ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) :925-934
[10]   Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli [J].
Bin, Cao ;
Hui, Wang ;
Zhu Renyuan ;
Ning Yongzhong ;
Xie Xiuli ;
Xu Yingchun ;
Zhu Yuanjue ;
Chen Minjun .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 56 (04) :351-357